Every healthcare professional who purchases medication is familiar with faxes from persistent direct sales companies that inundate the office with daily price lists. Regardless of the supplier, purchasing or using non-FDA-approved drug products exposes the physician to criminal and civil liability. The medication doesn’t even have to be counterfeit for the physician to suffer legal consequences.
Read MoreA pharmacist operating an online pharmacy in Washington DC has been indicted on fake online pharmacy charges, according to a press release from the FDA. In addition, a Florida-based doctor, has been charged with fulfilling prescriptions for said pharmacy for over 38,000 U.S. residents. Titilayo (Tomi) Akintomide Akinyoyenu, also known as Tommy Akin, was arrested…
Read MoreThe Canadian Department of Justice, along with the Royal Canadian Mounted Police (RCMP) have raided Kris Thorkleson’s Canada Drugs.com headquarters in Manitoba, the CBC reports. Speaking with the National Post, PSM Board member Jim Dahl expressed the opinion that the raids are a direct result of the ongoing investigation of counterfeit Avastin making it’s way…
Read MoreSamantha Gompel, the Intellectual Property Rights Communications Manager at the World Customs Organization (WCO), described the WCO’s efforts to help its 179 members secure and protect supply chains throughout global trade.
Read MoreWhen a drug counterfeiter makes fake medication, they do not go through dosage testing, quality control, or safety testing. The goal is to produce a product that looks like the real thing, with little concern for the actual ingredients. For this reason, all manner of toxic substances have made their way into counterfeit medication.
Read MorePSM board member Jim Dahl, the retired Assistant Director of the FDA’s Office of Criminal Investigations, spoke on our international panel about the Medicrime Convention, a new cross-European effort to address criminal issues involving medical products.
Read MoreWith the explosive growth of global medication counterfeiting crime rings, it is essential for policy makers across all disciplines to familiarize themselves with the counterfeit drug problem in the United States.
Read MoreAt PSM’s 2014 Interchange Gillian Buckley shared the Institute of Medicine’s Board on Global Health’s recommendations on how to stop the flow of fake medicines by supporting regulatory authorities and drug manufacturers in low to middle income countries.
Read MorePatients are always seeking ways to save money on medications and if they’re not careful they can open themselves up to dishonest vendors selling fake drugs. Learn how to save money safely.
Read MoreAt last year’s Interchange, we were pleased to have Tom Kubic, PSM’s treasurer and the president and CEO of the Pharmaceutical Security Institute (PSI), summarize trends in international drug counterfeiting activity and enforcement.
Read More